Smith & Nephew is a global medical technology company, established in 1856 and headquartered in Hull, England. The company designs and manufactures technology focused on the repair, regeneration, and replacement of soft and hard tissue. It operates in more than 100 countries worldwide, employing over 18,000 people and serving millions of patients annually.
The company's technical domains span orthopaedics, sports medicine, wound management, and robotics-assisted surgery. Its portfolio includes products such as the CORI Surgical System for robotics-assisted procedures, the PICO negative pressure wound therapy system, and the REGENETEN Bioinductive Implant for tissue regeneration. The firm is publicly listed on the London Stock Exchange (FTSE 100) and the New York Stock Exchange.
As a Brazilian subsidiary, BRA - Smith & Nephew Comercio de Produtos Medicos LTDA operates within this multinational framework, contributing to the company's global mission of leveraging technology for tissue repair and patient care.
